General Information of Target

Target ID LDTP06459
Target Name Myosin light chain kinase, smooth muscle (MYLK)
Gene Name MYLK
Gene ID 4638
Synonyms
MLCK; MLCK1; MYLK1; Myosin light chain kinase, smooth muscle; MLCK; smMLCK; EC 2.7.11.18; Kinase-related protein; KRP; Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MGDVKLVASSHISKTSLSVDPSRVDSMPLTEAPAFILPPRNLCIKEGATAKFEGRVRGYP
EPQVTWHRNGQPITSGGRFLLDCGIRGTFSLVIHAVHEEDRGKYTCEATNGSGARQVTVE
LTVEGSFAKQLGQPVVSKTLGDRFSAPAVETRPSIWGECPPKFATKLGRVVVKEGQMGRF
SCKITGRPQPQVTWLKGNVPLQPSARVSVSEKNGMQVLEIHGVNQDDVGVYTCLVVNGSG
KASMSAELSIQGLDSANRSFVRETKATNSDVRKEVTNVISKESKLDSLEAAAKSKNCSSP
QRGGSPPWAANSQPQPPRESKLESCKDSPRTAPQTPVLQKTSSSITLQAARVQPEPRAPG
LGVLSPSGEERKRPAPPRPATFPTRQPGLGSQDVVSKAANRRIPMEGQRDSAFPKFESKP
QSQEVKENQTVKFRCEVSGIPKPEVAWFLEGTPVRRQEGSIEVYEDAGSHYLCLLKARTR
DSGTYSCTASNAQGQLSCSWTLQVERLAVMEVAPSFSSVLKDCAVIEGQDFVLQCSVRGT
PVPRITWLLNGQPIQYARSTCEAGVAELHIQDALPEDHGTYTCLAENALGQVSCSAWVTV
HEKKSSRKSEYLLPVAPSKPTAPIFLQGLSDLKVMDGSQVTMTVQVSGNPPPEVIWLHNG
NEIQESEDFHFEQRGTQHSLCIQEVFPEDTGTYTCEAWNSAGEVRTQAVLTVQEPHDGTQ
PWFISKPRSVTASLGQSVLISCAIAGDPFPTVHWLRDGKALCKDTGHFEVLQNEDVFTLV
LKKVQPWHAGQYEILLKNRVGECSCQVSLMLQNSSARALPRGREPASCEDLCGGGVGADG
GGSDRYGSLRPGWPARGQGWLEEEDGEDVRGVLKRRVETRQHTEEAIRQQEVEQLDFRDL
LGKKVSTKTLSEDDLKEIPAEQMDFRANLQRQVKPKTVSEEERKVHSPQQVDFRSVLAKK
GTSKTPVPEKVPPPKPATPDFRSVLGGKKKLPAENGSSSAETLNAKAVESSKPLSNAQPS
GPLKPVGNAKPAETLKPMGNAKPAETLKPMGNAKPDENLKSASKEELKKDVKNDVNCKRG
HAGTTDNEKRSESQGTAPAFKQKLQDVHVAEGKKLLLQCQVSSDPPATIIWTLNGKTLKT
TKFIILSQEGSLCSVSIEKALPEDRGLYKCVAKNDAGQAECSCQVTVDDAPASENTKAPE
MKSRRPKSSLPPVLGTESDATVKKKPAPKTPPKAAMPPQIIQFPEDQKVRAGESVELFGK
VTGTQPITCTWMKFRKQIQESEHMKVENSENGSKLTILAARQEHCGCYTLLVENKLGSRQ
AQVNLTVVDKPDPPAGTPCASDIRSSSLTLSWYGSSYDGGSAVQSYSIEIWDSANKTWKE
LATCRSTSFNVQDLLPDHEYKFRVRAINVYGTSEPSQESELTTVGEKPEEPKDEVEVSDD
DEKEPEVDYRTVTINTEQKVSDFYDIEERLGSGKFGQVFRLVEKKTRKVWAGKFFKAYSA
KEKENIRQEISIMNCLHHPKLVQCVDAFEEKANIVMVLEIVSGGELFERIIDEDFELTER
ECIKYMRQISEGVEYIHKQGIVHLDLKPENIMCVNKTGTRIKLIDFGLARRLENAGSLKV
LFGTPEFVAPEVINYEPIGYATDMWSIGVICYILVSGLSPFMGDNDNETLANVTSATWDF
DDEAFDEISDDAKDFISNLLKKDMKNRLDCTQCLQHPWLMKDTKNMEAKKLSKDRMKKYM
ARRKWQKTGNAVRAIGRLSSMAMISGLSGRKSSTGSPTSPLNAEKLESEEDVSQAFLEAV
AEEKPHVKPYFSKTIRDLEVVEGSAARFDCKIEGYPDPEVVWFKDDQSIRESRHFQIDYD
EDGNCSLIISDVCGDDDAKYTCKAVNSLGEATCTAELIVETMEEGEGEGEEEEE
Target Type
Clinical trial
Target Bioclass
Enzyme
Family
Protein kinase superfamily, CAMK Ser/Thr protein kinase family
Subcellular location
Cytoplasm
Function
Calcium/calmodulin-dependent myosin light chain kinase implicated in smooth muscle contraction via phosphorylation of myosin light chains (MLC). Also regulates actin-myosin interaction through a non-kinase activity. Phosphorylates PTK2B/PYK2 and myosin light-chains. Involved in the inflammatory response (e.g. apoptosis, vascular permeability, leukocyte diapedesis), cell motility and morphology, airway hyperreactivity and other activities relevant to asthma. Required for tonic airway smooth muscle contraction that is necessary for physiological and asthmatic airway resistance. Necessary for gastrointestinal motility. Implicated in the regulation of endothelial as well as vascular permeability, probably via the regulation of cytoskeletal rearrangements. In the nervous system it has been shown to control the growth initiation of astrocytic processes in culture and to participate in transmitter release at synapses formed between cultured sympathetic ganglion cells. Critical participant in signaling sequences that result in fibroblast apoptosis. Plays a role in the regulation of epithelial cell survival. Required for epithelial wound healing, especially during actomyosin ring contraction during purse-string wound closure. Mediates RhoA-dependent membrane blebbing. Triggers TRPC5 channel activity in a calcium-dependent signaling, by inducing its subcellular localization at the plasma membrane. Promotes cell migration (including tumor cells) and tumor metastasis. PTK2B/PYK2 activation by phosphorylation mediates ITGB2 activation and is thus essential to trigger neutrophil transmigration during acute lung injury (ALI). May regulate optic nerve head astrocyte migration. Probably involved in mitotic cytoskeletal regulation. Regulates tight junction probably by modulating ZO-1 exchange in the perijunctional actomyosin ring. Mediates burn-induced microvascular barrier injury; triggers endothelial contraction in the development of microvascular hyperpermeability by phosphorylating MLC. Essential for intestinal barrier dysfunction. Mediates Giardia spp.-mediated reduced epithelial barrier function during giardiasis intestinal infection via reorganization of cytoskeletal F-actin and tight junctional ZO-1. Necessary for hypotonicity-induced Ca(2+) entry and subsequent activation of volume-sensitive organic osmolyte/anion channels (VSOAC) in cervical cancer cells. Responsible for high proliferative ability of breast cancer cells through anti-apoptosis.
TTD ID
T97141
Uniprot ID
Q15746
DrugMap ID
TT18ETS
Ensemble ID
ENST00000346322.10
HGNC ID
HGNC:7590
ChEMBL ID
CHEMBL2428

Target Site Mutations in Different Cell Lines

Cell line Mutation details Probe for labeling this protein in this cell
22RV1 SNV: p.C106Y .
AN3CA SNV: p.G1775E DBIA    Probe Info 
CAL51 SNV: p.G766D DBIA    Probe Info 
CASKI SNV: p.M1513I DBIA    Probe Info 
DETROIT562 SNV: p.Q1018R .
FTC133 SNV: p.A95T DBIA    Probe Info 
G361 SNV: p.R982C DBIA    Probe Info 
HCT116 Insertion: p.E653Ter .
HCT15 SNV: p.N813S .
HEC1B SNV: p.S998N .
HT SNV: p.K759N .
HT115 SNV: p.T1748M .
ICC3 SNV: p.R187Q DBIA    Probe Info 
IGR37 SNV: p.P750S .
IGR39 SNV: p.P750S DBIA    Probe Info 
MELJUSO SNV: p.L1350Q DBIA    Probe Info 
NB1 SNV: p.A50D; p.E1790A .
NCIH23 SNV: p.V278L DBIA    Probe Info 
OV90 SNV: p.M1513V DBIA    Probe Info 
OVCAR8 SNV: p.G902V DBIA    Probe Info 
OVK18 SNV: p.N1324T DBIA    Probe Info 
PC14 SNV: p.Y1353S .
RKO SNV: p.V199D DBIA    Probe Info 
SNGM SNV: p.G847V; p.A1127T; p.F1463V DBIA    Probe Info 
U87MG SNV: p.A1762V DBIA    Probe Info 
UMUC3 SNV: p.S13Y DBIA    Probe Info 
ZR751 SNV: p.E1414K DBIA    Probe Info 

Probe(s) Labeling This Target

ABPP Probe
Click To Hide/Show 4 Probe Related to This Target
Probe name Structure Binding Site(Ratio) Interaction ID Ref
IPM
 Probe Info 
N.A.  LDD0241  [1]
DBIA
 Probe Info 
C1305(1.16); C1307(1.16); C828(0.99); C832(0.99)  LDD0078  [2]
Phosphinate-6
 Probe Info 
N.A.  LDD0018  [3]
W1
 Probe Info 
N.A.  LDD0236  [1]
PAL-AfBPP Probe
Click To Hide/Show 1 Probe Related to This Target
Probe name Structure Binding Site(Ratio) Interaction ID Ref
DFG-out-4
 Probe Info 
9.20  LDD0075  [4]

Competitor(s) Related to This Target

Competitor ID Name Cell line Binding Site(Ratio) Interaction ID Ref
 LDCM0259  AC14 HEK-293T C297(1.13)  LDD1512  [5]
 LDCM0282  AC22 HEK-293T C297(0.70)  LDD1521  [5]
 LDCM0284  AC24 HEK-293T C435(0.96)  LDD1523  [5]
 LDCM0291  AC30 HEK-293T C297(1.05)  LDD1530  [5]
 LDCM0293  AC32 HEK-293T C435(0.98)  LDD1532  [5]
 LDCM0299  AC38 HEK-293T C297(0.84)  LDD1538  [5]
 LDCM0302  AC40 HEK-293T C435(1.10)  LDD1541  [5]
 LDCM0308  AC46 HEK-293T C297(1.28)  LDD1547  [5]
 LDCM0310  AC48 HEK-293T C435(1.13)  LDD1549  [5]
 LDCM0317  AC54 HEK-293T C297(1.06)  LDD1556  [5]
 LDCM0319  AC56 HEK-293T C435(1.02)  LDD1558  [5]
 LDCM0323  AC6 HEK-293T C297(1.14)  LDD1562  [5]
 LDCM0326  AC62 HEK-293T C297(0.93)  LDD1565  [5]
 LDCM0328  AC64 HEK-293T C435(1.04)  LDD1567  [5]
 LDCM0345  AC8 HEK-293T C435(1.12)  LDD1569  [5]
 LDCM0275  AKOS034007705 HEK-293T C435(1.05)  LDD1514  [5]
 LDCM0020  ARS-1620 HCC44 C1305(1.16); C1307(1.16); C828(0.99); C832(0.99)  LDD0078  [2]
 LDCM0367  CL1 HEK-293T C297(0.99)  LDD1571  [5]
 LDCM0368  CL10 HEK-293T C297(0.51)  LDD1572  [5]
 LDCM0370  CL101 HEK-293T C297(0.96)  LDD1574  [5]
 LDCM0374  CL105 HEK-293T C297(1.10)  LDD1578  [5]
 LDCM0378  CL109 HEK-293T C297(1.23)  LDD1582  [5]
 LDCM0383  CL113 HEK-293T C297(1.21)  LDD1587  [5]
 LDCM0387  CL117 HEK-293T C297(0.94)  LDD1591  [5]
 LDCM0390  CL12 HEK-293T C435(1.64)  LDD1594  [5]
 LDCM0392  CL121 HEK-293T C297(1.40)  LDD1596  [5]
 LDCM0396  CL125 HEK-293T C297(0.99)  LDD1600  [5]
 LDCM0400  CL13 HEK-293T C297(1.22)  LDD1604  [5]
 LDCM0410  CL22 HEK-293T C297(1.05)  LDD1614  [5]
 LDCM0412  CL24 HEK-293T C435(1.53)  LDD1616  [5]
 LDCM0413  CL25 HEK-293T C297(0.96)  LDD1617  [5]
 LDCM0423  CL34 HEK-293T C297(1.65)  LDD1627  [5]
 LDCM0425  CL36 HEK-293T C435(1.19)  LDD1629  [5]
 LDCM0426  CL37 HEK-293T C297(0.92)  LDD1630  [5]
 LDCM0436  CL46 HEK-293T C297(0.90)  LDD1640  [5]
 LDCM0438  CL48 HEK-293T C435(1.44)  LDD1642  [5]
 LDCM0439  CL49 HEK-293T C297(0.92)  LDD1643  [5]
 LDCM0449  CL58 HEK-293T C297(1.04)  LDD1652  [5]
 LDCM0452  CL60 HEK-293T C435(1.24)  LDD1655  [5]
 LDCM0453  CL61 HEK-293T C297(1.26)  LDD1656  [5]
 LDCM0463  CL70 HEK-293T C297(0.97)  LDD1666  [5]
 LDCM0465  CL72 HEK-293T C435(1.20)  LDD1668  [5]
 LDCM0466  CL73 HEK-293T C297(0.96)  LDD1669  [5]
 LDCM0476  CL82 HEK-293T C297(1.18)  LDD1679  [5]
 LDCM0478  CL84 HEK-293T C435(1.66)  LDD1681  [5]
 LDCM0479  CL85 HEK-293T C297(0.85)  LDD1682  [5]
 LDCM0489  CL94 HEK-293T C297(0.88)  LDD1692  [5]
 LDCM0491  CL96 HEK-293T C435(1.53)  LDD1694  [5]
 LDCM0492  CL97 HEK-293T C297(0.83)  LDD1695  [5]
 LDCM0017  DFG-out-2 A431 9.20  LDD0075  [4]
 LDCM0213  Electrophilic fragment 2 MDA-MB-231 C473(1.41); C297(0.90)  LDD1702  [6]
 LDCM0022  KB02 HEK-293T C83(0.94)  LDD1492  [5]
 LDCM0023  KB03 HEK-293T C83(0.96)  LDD1497  [5]
 LDCM0024  KB05 COLO792 C462(2.06); C83(1.79); C155(1.58)  LDD3310  [7]

The Interaction Atlas With This Target

The Protein(s) Related To This Target

Transporter and channel
Click To Hide/Show 1 Protein(s) Interacting with This Target
Protein name Family Uniprot ID
Golgi-associated PDZ and coiled-coil motif-containing protein (GOPC) . Q9HD26
Other
Click To Hide/Show 2 Protein(s) Interacting with This Target
Protein name Family Uniprot ID
Amyloid protein-binding protein 2 (APPBP2) . Q92624
SH2/SH3 adapter protein NCK1 (NCK1) . P16333

The Drug(s) Related To This Target

Approved
Click To Hide/Show 2 Drug(s) Interacting with This Target
Drug Name Drug Type External ID
Fostamatinib Small molecular drug DB12010
Ritodrine Small molecular drug DB00867
Phase 2
Click To Hide/Show 1 Drug(s) Interacting with This Target
Drug Name Drug Type External ID
Me-3407 Small molecular drug D0L8MO
Investigative
Click To Hide/Show 1 Drug(s) Interacting with This Target
Drug Name Drug Type External ID
Rki-1447 Small molecular drug D03CPB

References

1 Oxidant-Induced Bioconjugation for Protein Labeling in Live Cells. ACS Chem Biol. 2023 Jan 20;18(1):112-122. doi: 10.1021/acschembio.2c00740. Epub 2022 Dec 21.
2 Reimagining high-throughput profiling of reactive cysteines for cell-based screening of large electrophile libraries. Nat Biotechnol. 2021 May;39(5):630-641. doi: 10.1038/s41587-020-00778-3. Epub 2021 Jan 4.
3 DFT-Guided Discovery of Ethynyl-Triazolyl-Phosphinates as Modular Electrophiles for Chemoselective Cysteine Bioconjugation and Profiling. Angew Chem Int Ed Engl. 2022 Oct 10;61(41):e202205348. doi: 10.1002/anie.202205348. Epub 2022 Aug 22.
Mass spectrometry data entry: PXD033004
4 Affinity-based probes based on type II kinase inhibitors. J Am Chem Soc. 2012 Nov 21;134(46):19017-25. doi: 10.1021/ja306035v. Epub 2012 Nov 6.
5 Accelerating multiplexed profiling of protein-ligand interactions: High-throughput plate-based reactive cysteine profiling with minimal input. Cell Chem Biol. 2024 Mar 21;31(3):565-576.e4. doi: 10.1016/j.chembiol.2023.11.015. Epub 2023 Dec 19.
Mass spectrometry data entry: PXD044402
6 Nucleophilic covalent ligand discovery for the cysteine redoxome. Nat Chem Biol. 2023 Nov;19(11):1309-1319. doi: 10.1038/s41589-023-01330-5. Epub 2023 May 29.
Mass spectrometry data entry: PXD039908 , PXD029761
7 DrugMap: A quantitative pan-cancer analysis of cysteine ligandability. Cell. 2024 May 9;187(10):2536-2556.e30. doi: 10.1016/j.cell.2024.03.027. Epub 2024 Apr 22.
Mass spectrometry data entry: PXD047840